Johannes Clauss

Johannes Clauss serves as COO / CTO at AdjuCor GmbH. AdjuCor GmbH operates in the medical devices sector with approximately 31.0 employees. The company is headquartered in Munich, Bavaria. To date, AdjuCor GmbH has raised 35315700.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 1,671 executive contacts are available in Bavaria.
• • Our database includes 201,469 c suite-level executives.

Outlook Mobile Friendly Bootstrap Framework Apache Google Font API Vimeo WordPress.org Remote

medical equipment manufacturing heart failure biventricular support minimally invasive implanted device rebeat epicardial technology cardiac assist device bloodless design mechanical circulatory support patient-centered care natural blood flow advanced heart failure clinical trials feasibility study quality of life collaboration biomedical engineering innovative solutions preclinical testing revolutionary treatment clinical investigations shorter recovery time targeted assistance individualized support medical technology cost-effective treatment cardiovascular innovation synchronised force patient assistance cardiothoracic surgery healthcare solutions cutting-edge technology 3d printable materials pericardium safety & effectiveness regaining activities hospitalization costs stroke risk reduction device adaptability medical professionals scientific discovery research collaboration biomimetic polymers transplantation support cardiac mechanics european innovation council grants & funding medical devices hospital & health care health care health wellness & fitness

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Johannes Clauss in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at AdjuCor GmbH.

Johannes Clauss's Position in the MessageCEO Database

• •Johannes Clauss is 1 of 1 verified executive contact we track at AdjuCor GmbH.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,664 verified executive contacts in Bavaria are in the database.
• •31 verified contacts work at medical devices companies in the 31.0 employee range (same size as AdjuCor GmbH).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Johannes Clauss directly?

Johannes Clauss's verified email address is available to MessageCEO Pro subscribers. They currently serve as COO / CTO at AdjuCor GmbH. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Johannes Clauss work for?

Johannes Clauss is COO / CTO at AdjuCor GmbH, a company in the medical devices sector with 31.0 employees. The company is based in Munich, Bavaria.

Can I pitch or sell to Johannes Clauss?

As COO / CTO at AdjuCor GmbH, Johannes Clauss is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Johannes Clauss directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Johannes Clauss in?

Johannes Clauss works in the medical devices industry as COO / CTO at AdjuCor GmbH. MessageCEO provides verified contact information for executives across all major industries.

Is Johannes Clauss's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Johannes Clauss's profile is kept up-to-date with the latest available information.

Last updated: May 26, 2026